For practices that want one platform, not a suite.

One native platform — not a stitched-together suite.

Ensora's ABA suite stitches multiple products (incl. Catalyst data collection) under quote-only pricing. Wilma is one natively-built platform — built by people who actually ran ABA practices — with flat, published pricing. Agentic AI and a built-in phone are bonuses on top.

Why operators compare them

Why practices choose Wilma® over Ensora.

All-in-one, done right — built by operators.

Ensora's ABA suite combines separate products — practice management/billing plus Ensora Data Collection (formerly Catalyst) — that integrate rather than share one record. Wilma is one natively-built platform — data, notes, scheduling, billing, phone on a single record — built by people who actually ran ABA practices, so the whole thing is thought through end to end. That cohesion is the part operators call "impressive."

Flat, published pricing.

Ensora's ABA suite is quote-only, and data collection has historically been priced per client. Wilma publishes flat per-user pricing — $30/user Core, +$20 AI, +$10 phone — that you can evaluate without a sales call.

Agentic AI + built-in phone.

Wilma's agentic AI drafts notes from data and scrubs claims pre-submission, and the platform includes native telephony/IVR. Ensora doesn't advertise a built-in phone.

We'll be fair about Catalyst.

Catalyst (now Ensora Data Collection) is a mature, widely-used data-collection tool, and Ensora offers fully managed RCM services. Wilma's edge is a single native platform with flat pricing and agentic AI — not out-collecting Catalyst.

Side by side

Wilma® vs Ensora, feature by feature.

CapabilityWilmaEnsora
Single native platform (one record)✅ Native⚠️ Multi-product suite
Data collection✅ Native, included✅ Catalyst (mature)
Billing / RCM✅ Native + in-house✅ Incl. managed RCM service
Built-in phone & IVR✅ Native❌ Not advertised
Agentic AI (drafts, scrubs, prepares)✅ Core of the platform⚠️ AI features, not agentic
Pricing model✅ Flat $30/user, 10 min⚠️ Quote-only
Published pricing✅ Yes❌ Quote-only
Telehealth✅ Zoom / Teams / Meet integration✅ Yes

Comparison based on publicly available information as of June 2026. Ensora Health, Therapy Brands, and Catalyst are trademarks of their respective owners.

What you get on Wilma

What changes on one agentic platform.

No integration seams.

One codebase means no syncing between a PM product and a separate data-collection app — the record is the integration.

Price it without a sales call.

Flat per-user pricing you can model today, versus a quote-only suite.

Agentic AI + native phone.

Notes drafted from data, claims scrubbed, calls threaded to the record — built in, human-approved.

One vendor owns the whole system.

One roadmap and one support line instead of multiple products under one brand.

Pricing and reviews

Comparing Ensora ABA pricing and reviews? Start with the buying questions.

Bottom-funnel buyers usually need three answers: what it costs, what real operators say after implementation, and whether the platform owns the workflow or depends on add-ons.

Pricing clarity

Wilma publishes flat pricing: Core is $30/user/month with a 10-licence minimum, so an account starts at $300/month, plus optional AI and Phone add-ons. Use that as the baseline when an Ensora ABA pricing page or quote requires a sales process.

Review signals

When reading Ensora ABA reviews, separate ease-of-use praise from operational outcomes: clean claims, authorization control, onboarding speed, support responsiveness, and whether teams still need extra tools.

Native vs integrated

The strongest reviews usually come when scheduling, notes, billing, data, EVV, phone, and AI share one record. Every separate vendor adds another support path and another place work can drift.

FAQ

Questions operators ask before they switch.

Is Wilma a good Ensora ABA alternative?

What is Ensora, and what about Catalyst?

How does pricing compare?

Is Catalyst better at data collection?

Does Wilma include a phone system? Does Ensora?

Can I migrate from Ensora/Catalyst to Wilma?

Is Wilma HIPAA compliant?

See the whole platform in 30 minutes.

Bring your hardest workflow. We'll show you Wilma end to end — and a price you can model on one line.

Evaluating the switch

What to check when your product has been rebranded or acquired

When a product changes hands or changes name, the software is the same on Monday. What changes is the roadmap, the support model and the pricing trajectory — and those are what to ask about.

  • 1Where does your product sit in the portfolio?A product inside a larger family competes for engineering attention with its siblings. Ask which products are the strategic ones and where yours ranks. That ordering, not the feature list, determines whether the thing you need in eighteen months gets built.Red flag: No clear answer about investment priority between sibling products.
  • 2Has anything you rely on been deprecated?Consolidation usually means overlapping capabilities get rationalised. Get a written answer on whether any module you actively use is scheduled for sunset or migration into a sibling product.Red flag: Deprecations you learn about from release notes rather than an account manager.
  • 3Did support change hands?Support quality is what you actually consume daily. Ask whether your support team, escalation path and response targets changed after the transition, and check your own ticket history for the answer rather than taking theirs.Red flag: Longer resolution times since the transition that nobody has explained.
  • 4What is the renewal going to look like?Post-acquisition repricing is common and usually arrives at renewal. Ask what increases existing customers saw in the last two cycles, and get your own renewal terms in writing before you plan around them.Red flag: An uplift figure that is 'to be confirmed closer to the date'.

Before you sign

Questions worth asking on the demo

  • Which products in the portfolio are the strategic investment, and where does mine rank?
  • Is any module I use scheduled for deprecation or migration?
  • Did my support team or escalation path change, and what are the current targets?
  • What increases did existing customers see at the last two renewals?
  • What does data export contain if I leave — structured clinical data or documents?

Glossary

The terms you will hear

Product roadmap
What the vendor intends to build and when. For a product inside a larger portfolio, ask where it sits relative to the portfolio's other products — that ordering is what determines whether your requests get built.
Sunset
A vendor formally ending support for a product, usually with a migration path to a sibling product. Worth asking about directly rather than inferring from release notes.
Data portability
Getting your records out in a form another system can use. Document export is the weakest version; structured clinical data is the useful one.
Single record
Scheduling, data collection, notes and billing reading and writing the same rows rather than syncing between separate systems.

Keep reading

Related guides on running an ABA practice — the same operation, from a different angle.